Prescription drug · ANDA
Sodium Polystyrene Sulfonate NDC 46287-012
Sodium polystyrene sulfonate 1 g/g · Powder, For suspension · Oral, Rectal · CMP Pharma, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 46287-012-16 | 4628700121646287001216 | 454 g in 1 JAR (46287-012-16)Marketed from Jan 19, 1989 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sodium Polystyrene Sulfonate
- Generic name (nonproprietary)
- sodium polystyrene sulfonate
- Active ingredients
- Sodium polystyrene sulfonate — 1 g/g
- Dosage form
- Powder, For suspension
- Route
- Oral, Rectal
- Labeler
- CMP Pharma, Inc.NDC labeler code 46287
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 089910
- Marketing start
- Listing expires
- Identifiers
- Product ID 46287-012_ad780ec6-1a7e-4838-b833-6adb6bdbdb9aSPL ID ad780ec6-1a7e-4838-b833-6adb6bdbdb9aSPL set ID 2017bfbe-cda8-46f1-b4f1-9c086c3249a9RxCUI 2101899UNII 1699G8679ZUPC 0346287012160
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N446287001216followed by a unit qualifier and the quantityPackage 46287-0012-16. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
SODIUM POLYSTYRENE SULFONATE FOR SUSPENSION is indicated for the treatment of hyperkalemia. SODIUM POLYSTYRENE SULFONATE FOR SUSPENSION is a potassium binder indicated for the treatment of hyperkalemia ( 1 ). Limitation of Use: SODIUM POLYSTYRENE SULFONATE FOR SUSPENSION should not be used an emergency treatment for life threatening hyperkalemia because of its delayed onset of action ( 1 ). Limitation of Use: SODIUM POLYSTYRENE SULFONATE FOR SUSPENSION should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action [see Clinical Pharmacology (12.2) ] .
Excerpt only. Read the full label for complete information.
About NDC 46287-012
- What is NDC 46287-012?
- 46287-012 is the product NDC for Sodium Polystyrene Sulfonate, Sodium polystyrene sulfonate 1 g/g powder, for suspension, listed with the FDA by CMP Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Sodium Polystyrene Sulfonate.
- What is the active ingredient?
- Sodium polystyrene sulfonate.
- Who is the labeler?
- CMP Pharma, Inc., NDC labeler code 46287. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Sodium Polystyrene Sulfonate?
- 14 other product NDCs are listed under this name. See all Sodium Polystyrene Sulfonate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Sodium Polystyrene Sulfonate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 15 g/60mL | SuspensionOral, Rectal | Burel Pharmaceuticals, LLC | 35573-108 | 35573-0108-1435573-0108-57 |
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral, Rectal | SUNRISE PHARMACEUTICAL, INC. | 11534-166 | 11534-0166-1511534-0166-1611534-0166-44 |
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral, Rectal | Bryant Ranch Prepack | 63629-2390 | 63629-2390-01 |
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral, Rectal | Bryant Ranch Prepack | 63629-8849 | 63629-8849-01 |
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral, Rectal | Bryant Ranch Prepack | 63629-8850 | 63629-8850-01 |
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral, Rectal | Bryant Ranch Prepack | 71335-2855 | 71335-2855-01 |
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral, Rectal | Bryant Ranch Prepack | 72162-1230 | 72162-1230-0272162-1230-07 |
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral | PuraCap Laboratories, LLC | 24658-760 | 24658-0760-16 |
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral, Rectal | Chartwell RX, LLC | 62135-340 | 62135-0340-1162135-0340-5362135-0340-62 |
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral | ATLANTIC BIOLOGICALS CORP. | 17856-0024 | 17856-0024-0117856-0024-02 |